NasdaqGS:ICLRLife Sciences
ICON’s New US Clinics Test Early Phase Growth Against Stock Weakness
ICON (NasdaqGS:ICLR) has opened a new 69,500 square foot Clinical Research Unit in San Antonio.
The facility includes GMP/GCP pharmacy services, ISO cleanrooms, and expanded early phase clinical trial capacity.
New outpatient satellite clinics in Houston and Lawrence extend ICON's reach for trial recruitment and patient access.
ICON's new US clinical research expansion comes at a time when the stock has faced sustained pressure, with the share price at $116.78 and the company down 38.1%...